StockData
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. (RKDA) stock

RKDANasdaqBeveragesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.19−0.00 (-1.00%)

Close on Nov 18, 2026Market cap $452.45KP/E –Yield –

Arcadia Biosciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Arcadia Biosciences's revenue for the twelve months ending Jun 30, 2026 was $4.75M, down 12.2% year over year. For fiscal 2025 it was $4.86M, down 3.7% from the year before. Over ten years it grew -1.1% a year on average. The highest annual figure on record is $8.03M in fiscal 2020.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.86M-3.7%
FY2024Dec 31, 2024$5.05M+13.3%
FY2023Dec 31, 2023$4.45M-40.0%
FY2022Dec 31, 2022$7.42M+9.4%
FY2021Dec 31, 2021$6.78M-15.6%
FY2020Dec 31, 2020$8.03M+587.3%
FY2019Dec 31, 2019$1.17M-20.2%
FY2018Dec 31, 2018$1.46M-63.6%
FY2017Dec 31, 2017$4.03M+26.3%
FY2016Dec 31, 2016$3.19M-41.1%
FY2015Dec 31, 2015$5.41M-22.5%
FY2014Dec 31, 2014$6.98M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.44M-0.8%
Q1 FY2026Mar 31, 2026$1.10M-8.3%
Q4 FY2025Dec 31, 2025$901.00K-25.9%
Q3 FY2025Sep 30, 2025$1.30M-15.3%
Q2 FY2025Jun 30, 2025$1.46M+11.4%
Q1 FY2025Mar 31, 2025$1.20M+21.6%
Q4 FY2024Dec 31, 2024$1.22M+56.5%
Q3 FY2024Sep 30, 2024$1.54M+18.4%
Q2 FY2024Jun 30, 2024$1.31M+0.7%
Q1 FY2024Mar 31, 2024$987.00K-19.9%
Q4 FY2023Dec 31, 2023$777.00K+4.4%
Q3 FY2023Sep 30, 2023$1.30M-17.3%
Q2 FY2023Jun 30, 2023$1.30M-66.4%
Q1 FY2023Mar 31, 2023$1.23M-61.7%
Q4 FY2022Dec 31, 2022$744.00K-65.7%
Q3 FY2022Sep 30, 2022$1.57M-33.9%
Q2 FY2022Jun 30, 2022$3.86M+174.6%
Q1 FY2022Mar 31, 2022$3.22M+288.9%
Q4 FY2021Dec 31, 2021$2.17M-69.6%
Q3 FY2021Sep 30, 2021$2.38M+656.7%
Q2 FY2021Jun 30, 2021$1.41M+400.0%
Q1 FY2021Mar 31, 2021$828.00K+168.0%
Q4 FY2020Dec 31, 2020$7.13M+1613.9%
Q3 FY2020Sep 30, 2020$314.00K-19.9%
Q2 FY2020Jun 30, 2020$281.00K+38.4%
Q1 FY2020Mar 31, 2020$309.00K+95.6%
Q4 FY2019Dec 31, 2019$416.00K-6.3%
Q3 FY2019Sep 30, 2019$392.00K+5.9%
Q2 FY2019Jun 30, 2019$203.00K-53.4%
Q1 FY2019Mar 31, 2019$158.00K-26.2%
Q4 FY2018Dec 31, 2018$444.00K-68.9%
Q3 FY2018Sep 30, 2018$370.00K-37.2%
Q2 FY2018Jun 30, 2018$436.00K-56.0%
Q1 FY2018Mar 31, 2018$214.00K-79.0%
Q4 FY2017Dec 31, 2017$1.43M+164.4%
Q3 FY2017Sep 30, 2017$589.00K-45.2%
Q2 FY2017Jun 30, 2017$991.00K–
Q1 FY2017Mar 31, 2017$1.02M–
Q4 FY2016Dec 31, 2016$540.00K–
Q3 FY2016Sep 30, 2016$1.08M–

More Arcadia Biosciences figures

See a number that looks wrong?